Announcements - OBI Pharma 台灣浩鼎

2021.Aug.06

Announcement of the Consolidated Financial Statements for the second quarter of 2021 were authorized for issuance by the Board of Directors

2021.Jul.27

Patent of OBI-858 “Clostridium Botulinum toxin Type A composition, formulation and use thereof” was granted by the Taiwan Intellectual Property Office

2021.Jul.16

Announcement to approve the lifting of non-competition restrictions for directors at the 2021 Annual General Meeting

2021.Jul.16

Announcement on the elected Independent Director at the 2021 Annual General Meeting

2021.Jul.16

Announcement of resolution items from 2021 Annual General Meeting

2021.Jun.28

The Company’s Board of Directors resolved to change the date of 2021 Shareholders' Meeting in accordance with the instructions of FSC

2021.May.31

The company has acquired ordinary shares of Obigen Pharma, Inc.

2021.May.24

The company will postpone the annual shareholders’ meeting to June 21, 2021 in accordance with the instructions of FSC (distribution of electronic voting shareholders’ complimentary gift)

2021.May.20

The Company will postpone the Annual Shareholders' meeting on June 21, 2021 in accordance with the instructions of FSC

2021.May.19

Supplementary statement for 2021 shareholders’ meeting (change of location)

News

Latest News

Events

Latest events